Shanghai Fosun Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 16,952.397 million compared to CNY 14,028.164 million a year ago. Operating income was CNY 3,327.733 million compared to CNY 2,322.031 million a year ago. Net income was CNY 2,482.372 million compared to CNY 1,714.710 million a year ago. Basic earnings per share from continuing operations was CNY 0.97 compared to CNY 0.67 a year ago.